Search Results 371-380 of 17447 for bisphosphonates side effects

1. Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery - Mayo Clinic

   This pilot phase I trial studies the side effects and best way to give sirolimus, gemcitabine hydrochloride, and cisplatin in treating patients at high risk ...

2. Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. ... negative (≤ 1%), and HER2-negative;; BRCA ... Patients may receive bisphosphonates or denosumab ...

3. Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. In the later phase (phase ... Participants receiving bisphosphonate or denosumab therapy must have ...

4. A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer - Mayo Clinic

   ... side effects of enfortumab vedotin alone and with other anticancer therapies. A side effect is a response to a drug that is not part of the treatment effect.

5. Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma - Mayo Clinic

   Giving reduced craniospinal radiation therapy and chemotherapy may kill tumor cells and may also reduce the late side effects of treatment. Participation ...

6. enzyme supplements Archives - Mayo Clinic News Network

   -counter enzymes? Are there any side effects? Dr. Bauer: “Fortunately, for most over-the-counter enzymes, unless you're taking super-high ...

7. Non Clinical Trials - Mayo Clinic Research

   Giving lenalidomide together with rituximab and bendamustine hydrochloride may kill more cancer cells. PURPOSE: This phase I trial studies the side effects and ...

8. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

   About this study. This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who ...

9. Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. In the later phase (phase ... effect (i.e. megestrol acetate, bisphosphonates); these medications ...

10. Antidepressants and Bone Health - Mayo Clinic News Network

    ... adverse effects of anti-depressant drugs on bone.” The study included 3016 patients who had undergone pharmacogenetics testing between 2003 and 2013. Of ...